RNS Number : 0516L Renalytix PLC 18 April 2024     Renalytix plc ("Renalytix" or the "Company")   Renalytix Announces Management Change - Howard Doran Promoted to President   LONDON and SALT LAKE CITY , 18 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) announces that Howard Doran , who

RNS Number : 8404K Renalytix PLC 16 April 2024       Renalytix plc ("Renalytix" or the "Company")   Rule 2.9 Announcement   LONDON  and  SALT LAKE CITY , 16 April 2024  -  Renalytix plc  (NASDAQ: RNLX) (LSE: RENX), i n accordance with Rule 2.9 of the City Code on Takeovers and Mergers (" Takeover

RNS Number : 7824K Stifel Nicolaus Europe Limited 16 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 6814K Renalytix PLC 15 April 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

RNS Number : 6784K Renalytix PLC 15 April 2024     NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO  THE UNITED STATES ,  CANADA ,  AUSTRALIA ,  JAPAN  OR THE  REPUBLIC OF SOUTH AFRICA  OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD

RNS Number : 6091K Stifel Nicolaus Europe Limited 15 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 5019K Renalytix PLC 12 April 2024   S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares: Renalytix PLC 1b. Please indicate if the issuer is a non- UK issuer    (please mark with an "X"

RNS Number : 3586K Renalytix PLC 12 April 2024   Renalytix plc ("Renalytix" or the "Company")   Rule 2.9 Announcement   LONDON and SALT LAKE CITY -   12 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , in   accordance with Rule 2.9 of the City Code on Takeovers and Mergers and further

RNS Number : 0147K Stifel Nicolaus Europe Limited 10 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 0298K Renalytix PLC 10 April 2024   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares   LONDON and SALT LAKE CITY -   10 April 2024 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of principal and interest amount due under the